JM

Jyoti Mittal

Active Director Director DIN 08146551
DIN 08146551 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value •••• Premium profile

About Jyoti Mittal

Data last updated:

Jyoti Mittal is a Director at Suvision Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Suvision Pharmaceutical Private Limited reported revenue of ₹19.1 Lakh (FY 2024).

DIN 08146551
Primary Designation Director
Industry Pharma
First Appointment 30 May 2018
Oldest Company Age 8 yrs
Largest company Suvision Pharmaceutical Private Limited · ₹19.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20182018₹19.1 Lakh (FY 2024)Active

Board colleagues of Jyoti Mittal

NameDINCompanyDesignation
Choth Mittal Mal08146550Suvision Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Suvision Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jyoti Mittal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Mittal

Jyoti Mittal currently holds 1 directorship: Suvision Pharmaceutical Private Limited (Director, since 30 May 2018, revenue ₹19.1 Lakh (FY 2024)).

Jyoti Mittal was first appointed on 30 May 2018 as Director at Suvision Pharmaceutical Private Limited.

The current boards of Jyoti Mittal's companies include Choth Mittal Mal (Suvision Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available